Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache Society
Diener, Hans-Christoph (Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany)
Ashina, Messoud (University of Copenhagen)
Durand-Zaleski, Isabelle (Santé Publique Hôpital Henri Mondor, Créteil, France)
Kurth, Tobias (Charité-Universitätsmedizin Berlin)
Lantéri-Minet, Michel (Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France)
Lipton, Richard B. (Albert Einstein College of Medicine (Nova York, Estats Units d'Amèrica))
Ollendorf, Daniel A. (Value Measurement and Global Health Initiatives, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, , Boston, MA, USA)
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron)
Tassorelli, Cristina (Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy)
Terwindt, Gisela (Leiden University Medical Center)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Health technology assessment (HTA) ; Migraine ; Acute therapy ; Preventive treatment ; International Headache Society (IHS) ; Position statement
Publicat a:	Cephalalgia, Vol. 41 (january 2021) , p. 279-293, ISSN 1468-2982

DOI: 10.1177/0333102421989247
PMID: 33472427

15 p, 678.4 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats